[PDF][PDF] Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic

E Prompetchara, C Ketloy, T Palaga - Asian Pacific journal of …, 2020 - apjai-journal.org
As the world is witnessing the epidemic of COVID-19, a disease caused by a novel
coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path …

The comparative immunological characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 coronavirus infections

Y Zhang, B Li, B Ning - Frontiers in Immunology, 2020 - frontiersin.org
Immune dysfunction and aberrant cytokine storms often lead to rapid exacerbation of the
disease during late infection stages in SARS-CoV and MERS-CoV patients. However, the …

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies

S Molaei, M Dadkhah, V Asghariazar, C Karami… - International …, 2021 - Elsevier
The worldwide outbreak of SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
as a novel human coronavirus, was the worrying news at the beginning of 2020. Since its …

Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia

L Lin, L Lu, W Cao, T Li - Emerging microbes & infections, 2020 - Taylor & Francis
ABSTRACT Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact …

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics

K Dhama, K Sharun, R Tiwari, M Dadar… - Human vaccines & …, 2020 - Taylor & Francis
The novel coronavirus infection (COVID-19 or Coronavirus disease 2019) that emerged from
Wuhan, Hubei province of China has spread to many countries worldwide. Efforts have been …

[HTML][HTML] COVID-19: Unanswered questions on immune response and pathogenesis

E Maggi, GW Canonica, L Moretta - Journal of Allergy and Clinical …, 2020 - Elsevier
The novel coronavirus disease 2019 has rapidly increased in pandemic scale since it first
appeared in Wuhan, China, in December 2019. In these troubled days the scientific …

Lessons for COVID-19 immunity from other coronavirus infections

A Sariol, S Perlman - Immunity, 2020 - cell.com
A key goal to controlling coronavirus disease 2019 (COVID-19) is developing an effective
vaccine. Development of a vaccine requires knowledge of what constitutes a protective …

Immune responses and pathogenesis of SARS‐CoV‐2 during an outbreak in Iran: comparison with SARS and MERS

M Rokni, V Ghasemi, Z Tavakoli - Reviews in medical virology, 2020 - Wiley Online Library
The beginning of 2020 has seen the emergence of COVID‐19, an outbreak caused by a
novel coronavirus, SARS‐CoV‐2, an important pathogen for humans. There is an urgent …

[HTML][HTML] Innate and adaptive immune responses against coronavirus

A Hosseini, V Hashemi, N Shomali, F Asghari… - Biomedicine & …, 2020 - Elsevier
Coronaviruses (CoVs) are a member of the Coronaviridae family with positive‐sense single-
stranded RNA. In recent years, the CoVs have become a global problem to public health …

Vaccination strategies to combat novel corona virus SARS-CoV-2

SC Pandey, V Pande, D Sati, S Upreti, M Samant - Life sciences, 2020 - Elsevier
The 2019-novel coronavirus disease (COVID-19) is caused by SARS-CoV-2 is transmitted
from human to human has recently reported in China. Now COVID-19 has been spread all …